I'll ask this again. Also anyone know any other drugs having succes in breast cancer in phase II or III?
Also one more thing I would like input on. Is there any reason not to feel overly optimistic on tesmilifen. 50% improvement in life extension in all patients first phase 3. 142% improvement in life extension for those with mets within the first 3 years of diagnosis. The only drug to show life extension in the last 30 years for breast cancer is herceptin and these results seem much better then herception which only extended life by 33% in 25% of patients. I really would like to hear a few concerns on this drug.